Andrew Geyer
Pfizer (United States)(US)
Publications by Year
Research Areas
Protease and Inhibitor Mechanisms, Peroxisome Proliferator-Activated Receptors, Peptidase Inhibition and Analysis, Chemical Synthesis and Reactions, Coagulation, Bradykinin, Polyphosphates, and Angioedema
Most-Cited Works
- → Identification of Novel Binding Interactions in the Development of Potent, Selective 2-Naphthamidine Inhibitors of Urokinase. Synthesis, Structural Analysis, and SAR of N-Phenyl Amide 6-Substitution(2003)66 cited
- → Discovery of a Series of Imidazo[4,5-b]pyridines with Dual Activity at Angiotensin II Type 1 Receptor and Peroxisome Proliferator-Activated Receptor-γ(2011)52 cited
- → P2Y1 receptor antagonists as novel antithrombotic agents(2008)51 cited
- → Rasta Silanes: New Silyl Resins with Novel Macromolecular Architecture via Living Free Radical Polymerization(2000)41 cited
- → Interaction with the S1β-pocket of urokinase: 8-heterocycle substituted and 6,8-disubstituted 2-naphthamidine urokinase inhibitors(2004)28 cited
- → Naphthamidine urokinase plasminogen activator inhibitors with improved pharmacokinetic properties(2004)26 cited
- → Synthesis and SAR of selective benzothiophene, benzofuran, and indole-based peroxisome proliferator-activated receptor δ agonists(2007)24 cited
- → Discovery of highly potent and selective benzyloxybenzyl-based peroxisome proliferator-activator receptor (PPAR) δ agonists(2007)4 cited
- → Chlorosulfonyl Isocyanate(2005)1 cited